0001423173-13-000002.txt : 20130327 0001423173-13-000002.hdr.sgml : 20130327 20130327163159 ACCESSION NUMBER: 0001423173-13-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20130327 DATE AS OF CHANGE: 20130327 EFFECTIVENESS DATE: 20130327 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NEUROPHAGE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001423173 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-194074 FILM NUMBER: 13720344 BUSINESS ADDRESS: STREET 1: 222 THIRD STREET, SUITE 3120 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 1-617-714-5468 MAIL ADDRESS: STREET 1: 222 THIRD STREET, SUITE 3120 CITY: CAMBRIDGE STATE: MA ZIP: 02142 D 1 primary_doc.xml X0706 D LIVE 0001423173 NEUROPHAGE PHARMACEUTICALS INC 222 THIRD STREET, SUITE 3120 CAMBRIDGE MA MASSACHUSETTS 02142 1-617-714-5468 DELAWARE None None Corporation true Hampus Hillerstrom c/o NeuroPhage Pharmaceuticals, Inc. 222 Third Street, Suite 3120 Cambridge MA MASSACHUSETTS 02142 Executive Officer Vicki Sato c/o NeuroPhage Pharmaceuticals, Inc. 222 Third Street, Suite 3120 Cambridge MA MASSACHUSETTS 02142 Director Jonathan Solomon c/o NeuroPhage Pharmaceuticals, Inc. 222 Third Street, Suite 3120 Cambridge MA MASSACHUSETTS 02142 Executive Officer Director John Dee c/o NeuroPhage Pharmaceuticals, Inc. 222 Third Street, Suite 3120 Cambridge MA MASSACHUSETTS 02142 Director Paul Goldenheim c/o NeuroPhage Pharmaceuticals, Inc. 222 Third Street, Suite 3120 Cambridge MA MASSACHUSETTS 02142 Director Valerie Calenda c/o NeuroPhage Pharmaceuticals, Inc. 222 Third Street, Suite 3120 Cambridge MA MASSACHUSETTS 02142 Director Kenneth Buckfire c/o NeuroPhage Pharmaceuticals, Inc. 222 Third Street, Suite 3120 Cambridge MA MASSACHUSETTS 02142 Director Biotechnology Decline to Disclose 06 false 2013-03-14 false true true true false 0 8256229 3669479 4586750 false 31 0 0 0 false NEUROPHAGE PHARMACEUTICALS INC /s/ Hampus Hillerstrom Hampus Hillerstrom Executive Vice President 2013-03-27